Article(id=1304406858479988739, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304406828071281069, articleNumber=null, orderNo=null, doi=10.7501/j.issn.0253-2670.2026.02.016, pmid=null, cstr=null, oa=null, hot=0, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1761580800000, receivedDateStr=2025-10-28, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1788924429769, onlineDateStr=2026-09-09, pubDate=null, pubDateStr=null, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1788924429769, onlineIssueDateStr=2026-09-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1788924429769, creator=13701087609, updateTime=1788924429769, updator=13701087609, issue=Issue{id=1304406828071281069, tenantId=1146029695717560320, journalId=1302319053441957962, year='2026', volume='57', issue='2', pageStart='393', pageEnd='788', issueExtLink='null', onlineDate='null', pubDate='1769529600000', pubDateStr='2026-01-28', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1788924422518, creator='13701087609', updateTime=1788924652596, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1304407793138688830, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304406828071281069, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1304407793138688831, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304406828071281069, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=564, endPage=573, ext={EN=ArticleExt(id=1304406858840698885, articleId=1304406858479988739, tenantId=1146029695717560320, journalId=1302319053441957962, language=EN, title=Mechanism of galangin-induced apoptosis of hepatocellular carcinoma based on network pharmacology, molecular docking and cell experiment, columnId=null, journalTitle=Chinese Traditional and Herbal Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=Objective To explore the mechanism of galangin-induced apoptosis in hepatocellular carcinoma (HCC) based on network pharmacology, molecular docking and cell experiment. Methods Potential targets of galangin were predicted using SwissTargetPrediction and PharmMapper databases, HCC-related targets were collected from GeneCards, TTD and OMIM databases. The intersection of these targets was used to construct a protein-protein interaction (PPI) network via STRING database, followed by gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis of intersected targets using DAVID platform. Molecular docking of galangin with core targets was validated using AutoDock Vina. Human hepatocellular carcinoma PLC/PRF/5 cells were cultured in vitro, and the effects of galangin on cell viability and apoptosis were assessed using CCK-8 assay and flow cytometry. Western blotting was used to detect the expressions of epidermal growth factor receptor (EGFR)-phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway and apoptosis-related proteins. Results Network pharmacology analysis identified 142 common targets between galangin and HCC. PPI network analysis revealed that proteins such as EGFR, Akt and cystein-asparate protease-3 (Caspase-3) may serve as core targets. GO and KEGG analyses suggested that galangin primarily influenced cellular processes by regulating PI3K/Akt signaling pathway. Molecular docking results indicated galangin had strong binding affinity with targets such as EGFR. In vitro experiments confirmed that galangin significantly inhibited PLC/PRF/5 cells viability and induced apoptosis (P < 0.01, 0.001), significantly down-regulated p-EGFR and p-Akt protein expressions (P < 0.05), and significantly up-regulated cleaved Caspase-3 and Caspase-9 protein expressions (P < 0.05, 0.01). Conclusion Galangin may exert its anti-HCC effects by inhibiting EGFR-PI3K/Akt signaling pathway and inducing apoptosis in HCC cells., authors=Gulijiamali Kahaer, XIE Wenchen, PAN Sirun, WANG Han, LU Yan, authorsList=Gulijiamali Kahaer, XIE Wenchen, PAN Sirun, WANG Han, LU Yan, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1304406858773590020, articleId=1304406858479988739, tenantId=1146029695717560320, journalId=1302319053441957962, language=CN, title=基于网络药理学、分子对接及细胞实验探究高良姜素诱导肝细胞癌凋亡的作用机制, columnId=1304140191707456168, journalTitle=中草药, columnName=药理与临床, runingTitle=null, highlight=null, articleAbstract=目的 基于网络药理学、分子对接及细胞实验探究高良姜素诱导肝细胞癌(hepatocellular carcinoma,HCC)凋亡的作用机制。方法 利用SwissTargetPrediction与PharmMapper数据库预测高良姜素的潜在作用靶点;从GeneCards、TTD与OMIM数据库获取HCC相关靶点。二者取交集后,通过STRING数据库构建蛋白质-相互作用(protein-protein interaction,PPI)网络,并利用DAVID平台对交集靶点进行基因本体(gene ontology,GO)功能与京都基因与基因组百科全书(Kyoto encyclopedia of genes and genomes,KEGG)通路富集分析。采用AutoDock Vina对高良姜素与核心靶点进行分子对接验证。体外培养人肝癌PLC/PRF/5细胞,通过CCK-8法与流式细胞术分别检测高良姜素对细胞活力与凋亡的影响,并利用Western blotting检测表皮生长因子受体(epidermal growth factor receptor,EGFR)-磷脂酰肌醇3-激酶(phosphatidylinositol 3-kinase,PI3K)/蛋白激酶B(protein kinase B,Akt)信号通路及凋亡相关蛋白表达。结果 网络药理学分析共获得高良姜素与HCC的共同作用靶点142个。PPI网络分析显示,EGFR、Akt和半胱氨酸天冬氨酸蛋白酶-3(cystein-asparate protease-3,Caspase-3)等蛋白可能是其核心作用靶点。GO与KEGG分析提示,高良姜素可能主要通过调控PI3K/Akt等信号通路影响细胞进程。分子对接结果表明,高良姜素与EGFR等靶点具有较强的结合能力。体外实验证实,高良姜素能显著抑制PLC/PRF/5细胞活力并诱导细胞凋亡(P<0.01、0.001),显著下调p-EGFR和p-Akt的蛋白表达(P<0.05),显著上调cleaved Caspase-3和Caspase-9的蛋白表达(P<0.05、0.01)。结论 高良姜素可能通过抑制EGFR-PI3K/Akt信号通路,诱导HCC细胞凋亡,从而发挥抗HCC的作用。, authors=古丽加马力·卡哈尔1, 谢汶辰1, 潘思润1, 王晗1, 鲁琰1, authorsList=古丽加马力·卡哈尔, 谢汶辰, 潘思润, 王晗, 鲁琰, authorCompany=1 海南医科大学基础医学院, 热带转化医学教育部重点实验室和海南省肿瘤发生和干预重点实验室, 海南 海口 571199, correspAuthors=王晗, authorNote=古丽加马力·卡哈尔: 古丽加马力·卡哈尔,硕士研究生,研究方向为中药抗肿瘤分子机制研究。E-mail: 1317413591@qq.com, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=6hw+YkjAIrAZZFwzGYGLUA==, pdfFileSize=1954330, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=海南省重点研发项目 (ZDYF2024SHFZ118); 海南医科大学学术提升计划项目 (XSTS2025070); 海南医科大学大学生创新创业训练计划项目 (202511810008,X202511810068))}, authors=null, keywords=[Keyword(id=1304406859159465990, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406858479988739, language=CN, orderNo=1, keyword=高良姜素), Keyword(id=1304406859247546375, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406858479988739, language=CN, orderNo=2, keyword=肝细胞癌), Keyword(id=1304406859314655240, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406858479988739, language=CN, orderNo=3, keyword=网络药理学), Keyword(id=1304406859507593225, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406858479988739, language=CN, orderNo=4, keyword=凋亡), Keyword(id=1304406859591479306, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406858479988739, language=CN, orderNo=5, keyword=EGFR-PI3K/Akt信号通路), Keyword(id=1304406859696336907, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406858479988739, language=EN, orderNo=1, keyword=galangin), Keyword(id=1304406859750862860, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406858479988739, language=EN, orderNo=2, keyword=hepatocellular carcinoma), Keyword(id=1304406859809583117, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406858479988739, language=EN, orderNo=3, keyword=network pharmacology), Keyword(id=1304406859864109070, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406858479988739, language=EN, orderNo=4, keyword=apoptosis), Keyword(id=1304406859931217935, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304406858479988739, language=EN, orderNo=5, keyword=EGFR-PI3K/Akt signaling pathway)], refs=null, funds=null, companyList=null, figs=null, attaches=null, journal=Journal(id=1302309778002903112, delFlag=0, nameCn=中草药, nameEn=Chinese Traditional and Herbal Drugs, nameHistory1=null, nameHistory2=null, issn=0253-2670, eissn=null, cn=12-1108/R, coden=null, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=cGpSKCP11AF8PAOcTXYWfg==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Traditional and Herbal Drugs, journalRemark=null, publicationField=null, createdTime=1788424446827, updatedTime=1788949289390, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=cGpSKCP11AF8PAOcTXYWfg==, picEn=Xw//kxUC3ON4eHxev0QLhQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1304511127375863983, language=CN, name=中草药, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788949289411, updatedTime=1788949289411, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://www.tiprpress.com/zcy/author/login, submissionEditorUrl=https://www.tiprpress.com/zcy/editor/login, submissionReviewUrl=https://www.tiprpress.com/zcy/reviewer/login, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304511127442972848, language=EN, name=Chinese Traditional and Herbal Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788949289427, updatedTime=1788949289427, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://www.tiprpress.com/zcy/author/login, submissionEditorUrl=https://www.tiprpress.com/zcy/editor/login, submissionReviewUrl=https://www.tiprpress.com/zcy/reviewer/login, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1302319053441957962, websiteList=[Website(id=1302319176408912052, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1302319053441957962, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zcy/CN, language=CN, createTime=1788426687576, createBy=18614031015, updateTime=1788427346252, updateBy=18614031015, name=中草药-中文, tplId=1146099689490845704, title=中草药, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1302322043651904087, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=articleTextType, value=kx, createTime=1788427371180, updateTime=1788427371180, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043593183828, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=banner, value=null, createTime=1788427371166, updateTime=1788427371166, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043672875610, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=grayFlag, value=0, createTime=1788427371185, updateTime=1788427371185, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043584795219, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=logo, value=https://castjournals.cast.org.cn/joweb/zcy/CN/file/pic?fileId=uiD1gpiRqR++OLOz4iKzDg==, createTime=1788427371164, updateTime=1788427371164, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043689652828, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=minRunFlag, value=0, createTime=1788427371189, updateTime=1788427371189, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043643515478, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zcy/CN/file/pic, createTime=1788427371178, updateTime=1788427371178, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043681264219, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=silenceFlag, value=0, createTime=1788427371187, updateTime=1788427371187, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043601572437, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1788427371168, updateTime=1788427371168, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043660292696, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=themeColor, value=null, createTime=1788427371182, updateTime=1788427371182, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043668681305, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=themeStyle, value=null, createTime=1788427371184, updateTime=1788427371184, creator=18614031015, updator=18614031015)]), Website(id=1302319176715096246, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1302319053441957962, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zcy/EN, language=EN, createTime=1788426687649, createBy=18614031015, updateTime=1788427341161, updateBy=18614031015, name=中草药-英文, tplId=1146101810881728533, title=Chinese Traditional and Herbal Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1302322015206134340, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=articleTextType, value=kx, createTime=1788427364398, updateTime=1788427364398, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015185162817, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=banner, value=null, createTime=1788427364393, updateTime=1788427364393, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015227105863, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=grayFlag, value=0, createTime=1788427364403, updateTime=1788427364403, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015176774208, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=logo, value=https://castjournals.cast.org.cn/joweb/zcy/EN/file/pic?fileId=uiD1gpiRqR++OLOz4iKzDg==, createTime=1788427364391, updateTime=1788427364391, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015239688777, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=minRunFlag, value=0, createTime=1788427364406, updateTime=1788427364406, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015201940035, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zcy/EN/file/pic, createTime=1788427364397, updateTime=1788427364397, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015235494472, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=silenceFlag, value=0, createTime=1788427364405, updateTime=1788427364405, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015193551426, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1788427364395, updateTime=1788427364395, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015214522949, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=themeColor, value=null, createTime=1788427364400, updateTime=1788427364400, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015218717254, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=themeStyle, value=null, createTime=1788427364401, updateTime=1788427364401, creator=18614031015, updator=18614031015)])], journalTitle=中草药, weixinUrl=null, journalUrl=https://www.tiprpress.com/zcy, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Traditional and Herbal Drugs, journalPhotoCn=cGpSKCP11AF8PAOcTXYWfg==, journalPhotoEn=Xw//kxUC3ON4eHxev0QLhQ==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.02.016, detailUrlEn=https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2026.02.016, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zcy/CN/PDF/10.7501/j.issn.0253-2670.2026.02.016, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zcy/EN/PDF/10.7501/j.issn.0253-2670.2026.02.016, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1788924429769, fullTextJson=null, articleText=null, reference=江宁, 李旭初, 黄慧瑶, 等. T细胞免疫受体单抗联合疗法于晚期肝细胞癌一线治疗中的应用与挑战:基于两项Ⅱ期临床研究结果的述评[J]. 肝癌电子杂志, 2024, 11(4):6-12.
曹梦迪, 陈万青. GLOBOCAN 2022全球癌症统计数据解读[J]. 中国医学前沿杂志:电子版, 2024, 16(6):1-5.
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3):229-263.
Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14(CONCORD-3):Analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J]. Lancet, 2018, 391(10125):1023-1075.
McGlynn K A, Petrick J L, El-Serag H B. Epidemiology of hepatocellular carcinoma[J]. Hepatology, 2021, 73(Suppl 1):4-13.
Zhou Y, Wang Z, Ren S, et al. Mechanism of action of protopanaxadiol ginsenosides on hepatocellular carcinoma and network pharmacological analysis[J]. Chin Herb Med, 2024, 16(4):548-557.
Vogel A, Meyer T, Sapisochin G, et al. Hepatocellular carcinoma[J]. Lancet, 2022, 400(10360):1345-1362.
Tabrizian P, Jibara G, Shrager B, et al. Recurrence of hepatocellular cancer after resection:Patterns, treatments, and prognosis[J]. Ann Surg, 2015, 261(5):947-955.
Zhu Y J, Zheng B, Wang H Y, et al. New knowledge of the mechanisms of sorafenib resistance in liver cancer[J]. Acta Pharmacol Sin, 2017, 38(5):614-622.
Finn R S, Qin S K, Ikeda M, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma[J]. N Engl J Med, 2020, 382(20):1894-1905.
Wu Y Z, Luo J H, Xu B J. Insights into the anticancer effects of galangal and galangin:A comprehensive review[J]. Phytomedicine, 2024, 135:156085.
Matsuda H, Morikawa T, Ando S, et al. Structural requirements of flavonoids for nitric oxide production inhibitory activity and mechanism of action[J]. Bioorg Med Chem, 2003, 11(9):1995-2000.
Zhang W J, Lan Y, Huang Q L, et al. Galangin induces B16F10 melanoma cell apoptosis via mitochondrial pathway and sustained activation of p38 MAPK[J]. Cytotechnology, 2013, 65(3):447-455.
Zheng J J, Wang S Y, Xia L, et al. Hepatocellular carcinoma:Signaling pathways and therapeutic advances[J]. Signal Transduct Target Ther, 2025, 10(1):35.
Zhang H T, Luo H, Wu J, et al. Galangin induces apoptosis of hepatocellular carcinoma cells via the mitochondrial pathway[J]. World J Gastroenterol, 2010, 16(27):3377-3384.
刘小飞, 林开文. 海南姜科植物药用价值研究进展[J]. 海南医学院学报, 2024, 30(5):383-389.
王晓晴, 孙允红, 赵方舒, 等. 高良姜素的药理作用及机制研究进展[J]. 中药药理与临床, 2023, 39(8):115-120.
Hopkins A L. Network pharmacology:The next paradigm in drug discovery[J]. Nat Chem Biol, 2008, 4(11):682-690.
刘志华, 孙晓波. 网络药理学:中医药现代化的新机遇[J]. 药学学报, 2012, 47(6):696-703.
Uppathi P, Rajakumari S, Saritha K V. Molecular docking:An emerging tool for target-based cancer therapy[J]. Crit Rev Oncog, 2025, 30(1):1-13.
Shoemaker R H. The NCI60 human tumour cell line anticancer drug screen[J]. Nat Rev Cancer, 2006, 6(10):813-823.
Stelzer G, Rosen N, Plaschkes I, et al. The GeneCards suite:From gene data mining to disease genome sequence analyses[J]. Curr Protoc Bioinformatics, 2016, 54:1.30.1-1.30.1.30.33.
Amberger J S, Bocchini C A, Scott A F, et al. OMIM.org:Leveraging knowledge across phenotype-gene relationships[J]. Nucleic Acids Res, 2019, 47(D1):D1038-D1043.
王与菲, 张海婧, 吴练秋. 基于网络药理学对黄连抗结直肠癌作用机制的分析[J]. 世界科学技术-中医药现代化, 2021, 23(1):136-146.
郭紫文, 王艳, 陶伟伟, 等. 基于网络药理学、分子对接及细胞实验验证探讨藏红花素改善阿尔茨海默病的作用机制[J]. 中草药, 2025, 56(13):4712-4723.
王紫柠, 蒲浩, 王清如, 等. 基于网络药理学和实验验证探讨丹皮酚对酒精性肝病小鼠的作用机制[J]. 中草药, 2025, 56(18):6644-6656.
廖春红, 李凤珍, 刘霞, 等. 基于网络药理学和分子对接技术探讨当归四逆加吴茱萸生姜汤治疗子宫内膜异位症的分子机制[J]. 广西医学, 2024, 46(10):1545-1554.
曹寒晶, 王煦焱, 高腾, 等. 基于网络药理学和实验验证探讨沙棘治疗代谢相关脂肪性肝病的作用机制[J]. 药物评价研究, 2025, 48(8):2154-2163.)
收藏切换
基于网络药理学、分子对接及细胞实验探究高良姜素诱导肝细胞癌凋亡的作用机制
收藏切换
PDF下载
中草药 | 药理与临床 2026,57(2): 564-573
收起
收藏切换
中草药 |药理与临床 2026 , 57 (2) : 564 -573
基于网络药理学、分子对接及细胞实验探究高良姜素诱导肝细胞癌凋亡的作用机制
全屏
古丽加马力·卡哈尔1, 谢汶辰1, 潘思润1, 王晗1, 鲁琰1
作者信息
    1 海南医科大学基础医学院, 热带转化医学教育部重点实验室和海南省肿瘤发生和干预重点实验室, 海南 海口 571199
通讯作者:
王晗
作者简介:
古丽加马力·卡哈尔: 古丽加马力·卡哈尔,硕士研究生,研究方向为中药抗肿瘤分子机制研究。E-mail: 1317413591@qq.com
Mechanism of galangin-induced apoptosis of hepatocellular carcinoma based on network pharmacology, molecular docking and cell experiment
  • Gulijiamali Kahaer, XIE Wenchen, PAN Sirun, WANG Han, LU Yan
  • Affiliations
    doi: 10.7501/j.issn.0253-2670.2026.02.016
    文章导航
    收藏切换
    目的 基于网络药理学、分子对接及细胞实验探究高良姜素诱导肝细胞癌(hepatocellular carcinoma,HCC)凋亡的作用机制。方法 利用SwissTargetPrediction与PharmMapper数据库预测高良姜素的潜在作用靶点;从GeneCards、TTD与OMIM数据库获取HCC相关靶点。二者取交集后,通过STRING数据库构建蛋白质-相互作用(protein-protein interaction,PPI)网络,并利用DAVID平台对交集靶点进行基因本体(gene ontology,GO)功能与京都基因与基因组百科全书(Kyoto encyclopedia of genes and genomes,KEGG)通路富集分析。采用AutoDock Vina对高良姜素与核心靶点进行分子对接验证。体外培养人肝癌PLC/PRF/5细胞,通过CCK-8法与流式细胞术分别检测高良姜素对细胞活力与凋亡的影响,并利用Western blotting检测表皮生长因子受体(epidermal growth factor receptor,EGFR)-磷脂酰肌醇3-激酶(phosphatidylinositol 3-kinase,PI3K)/蛋白激酶B(protein kinase B,Akt)信号通路及凋亡相关蛋白表达。结果 网络药理学分析共获得高良姜素与HCC的共同作用靶点142个。PPI网络分析显示,EGFR、Akt和半胱氨酸天冬氨酸蛋白酶-3(cystein-asparate protease-3,Caspase-3)等蛋白可能是其核心作用靶点。GO与KEGG分析提示,高良姜素可能主要通过调控PI3K/Akt等信号通路影响细胞进程。分子对接结果表明,高良姜素与EGFR等靶点具有较强的结合能力。体外实验证实,高良姜素能显著抑制PLC/PRF/5细胞活力并诱导细胞凋亡(P<0.01、0.001),显著下调p-EGFR和p-Akt的蛋白表达(P<0.05),显著上调cleaved Caspase-3和Caspase-9的蛋白表达(P<0.05、0.01)。结论 高良姜素可能通过抑制EGFR-PI3K/Akt信号通路,诱导HCC细胞凋亡,从而发挥抗HCC的作用。
    高良姜素  /  肝细胞癌  /  网络药理学  /  凋亡  /  EGFR-PI3K/Akt信号通路
    Objective To explore the mechanism of galangin-induced apoptosis in hepatocellular carcinoma (HCC) based on network pharmacology, molecular docking and cell experiment. Methods Potential targets of galangin were predicted using SwissTargetPrediction and PharmMapper databases, HCC-related targets were collected from GeneCards, TTD and OMIM databases. The intersection of these targets was used to construct a protein-protein interaction (PPI) network via STRING database, followed by gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis of intersected targets using DAVID platform. Molecular docking of galangin with core targets was validated using AutoDock Vina. Human hepatocellular carcinoma PLC/PRF/5 cells were cultured in vitro, and the effects of galangin on cell viability and apoptosis were assessed using CCK-8 assay and flow cytometry. Western blotting was used to detect the expressions of epidermal growth factor receptor (EGFR)-phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway and apoptosis-related proteins. Results Network pharmacology analysis identified 142 common targets between galangin and HCC. PPI network analysis revealed that proteins such as EGFR, Akt and cystein-asparate protease-3 (Caspase-3) may serve as core targets. GO and KEGG analyses suggested that galangin primarily influenced cellular processes by regulating PI3K/Akt signaling pathway. Molecular docking results indicated galangin had strong binding affinity with targets such as EGFR. In vitro experiments confirmed that galangin significantly inhibited PLC/PRF/5 cells viability and induced apoptosis (P < 0.01, 0.001), significantly down-regulated p-EGFR and p-Akt protein expressions (P < 0.05), and significantly up-regulated cleaved Caspase-3 and Caspase-9 protein expressions (P < 0.05, 0.01). Conclusion Galangin may exert its anti-HCC effects by inhibiting EGFR-PI3K/Akt signaling pathway and inducing apoptosis in HCC cells.
    galangin  /  hepatocellular carcinoma  /  network pharmacology  /  apoptosis  /  EGFR-PI3K/Akt signaling pathway
    古丽加马力·卡哈尔, 谢汶辰, 潘思润, 王晗, 鲁琰. 基于网络药理学、分子对接及细胞实验探究高良姜素诱导肝细胞癌凋亡的作用机制. 中草药, 2026 , 57 (2) : 564 -573 . DOI: 10.7501/j.issn.0253-2670.2026.02.016
    Gulijiamali Kahaer, XIE Wenchen, PAN Sirun, WANG Han, LU Yan. Mechanism of galangin-induced apoptosis of hepatocellular carcinoma based on network pharmacology, molecular docking and cell experiment[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (2) : 564 -573 . DOI: 10.7501/j.issn.0253-2670.2026.02.016

      海南省重点研发项目 (ZDYF2024SHFZ118); 海南医科大学学术提升计划项目 (XSTS2025070); 海南医科大学大学生创新创业训练计划项目 (202511810008,X202511810068)

    参考文献 引证文献
    排序方式:
    江宁, 李旭初, 黄慧瑶, 等. T细胞免疫受体单抗联合疗法于晚期肝细胞癌一线治疗中的应用与挑战:基于两项Ⅱ期临床研究结果的述评[J]. 肝癌电子杂志, 2024, 11(4):6-12.
    曹梦迪, 陈万青. GLOBOCAN 2022全球癌症统计数据解读[J]. 中国医学前沿杂志:电子版, 2024, 16(6):1-5.
    Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3):229-263.
    Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14(CONCORD-3):Analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J]. Lancet, 2018, 391(10125):1023-1075.
    McGlynn K A, Petrick J L, El-Serag H B. Epidemiology of hepatocellular carcinoma[J]. Hepatology, 2021, 73(Suppl 1):4-13.
    Zhou Y, Wang Z, Ren S, et al. Mechanism of action of protopanaxadiol ginsenosides on hepatocellular carcinoma and network pharmacological analysis[J]. Chin Herb Med, 2024, 16(4):548-557.
    Vogel A, Meyer T, Sapisochin G, et al. Hepatocellular carcinoma[J]. Lancet, 2022, 400(10360):1345-1362.
    Tabrizian P, Jibara G, Shrager B, et al. Recurrence of hepatocellular cancer after resection:Patterns, treatments, and prognosis[J]. Ann Surg, 2015, 261(5):947-955.
    Zhu Y J, Zheng B, Wang H Y, et al. New knowledge of the mechanisms of sorafenib resistance in liver cancer[J]. Acta Pharmacol Sin, 2017, 38(5):614-622.
    Finn R S, Qin S K, Ikeda M, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma[J]. N Engl J Med, 2020, 382(20):1894-1905.
    Wu Y Z, Luo J H, Xu B J. Insights into the anticancer effects of galangal and galangin:A comprehensive review[J]. Phytomedicine, 2024, 135:156085.
    Matsuda H, Morikawa T, Ando S, et al. Structural requirements of flavonoids for nitric oxide production inhibitory activity and mechanism of action[J]. Bioorg Med Chem, 2003, 11(9):1995-2000.
    Zhang W J, Lan Y, Huang Q L, et al. Galangin induces B16F10 melanoma cell apoptosis via mitochondrial pathway and sustained activation of p38 MAPK[J]. Cytotechnology, 2013, 65(3):447-455.
    Zheng J J, Wang S Y, Xia L, et al. Hepatocellular carcinoma:Signaling pathways and therapeutic advances[J]. Signal Transduct Target Ther, 2025, 10(1):35.
    Zhang H T, Luo H, Wu J, et al. Galangin induces apoptosis of hepatocellular carcinoma cells via the mitochondrial pathway[J]. World J Gastroenterol, 2010, 16(27):3377-3384.
    刘小飞, 林开文. 海南姜科植物药用价值研究进展[J]. 海南医学院学报, 2024, 30(5):383-389.
    王晓晴, 孙允红, 赵方舒, 等. 高良姜素的药理作用及机制研究进展[J]. 中药药理与临床, 2023, 39(8):115-120.
    Hopkins A L. Network pharmacology:The next paradigm in drug discovery[J]. Nat Chem Biol, 2008, 4(11):682-690.
    刘志华, 孙晓波. 网络药理学:中医药现代化的新机遇[J]. 药学学报, 2012, 47(6):696-703.
    Uppathi P, Rajakumari S, Saritha K V. Molecular docking:An emerging tool for target-based cancer therapy[J]. Crit Rev Oncog, 2025, 30(1):1-13.
    Shoemaker R H. The NCI60 human tumour cell line anticancer drug screen[J]. Nat Rev Cancer, 2006, 6(10):813-823.
    Stelzer G, Rosen N, Plaschkes I, et al. The GeneCards suite:From gene data mining to disease genome sequence analyses[J]. Curr Protoc Bioinformatics, 2016, 54:1.30.1-1.30.1.30.33.
    Amberger J S, Bocchini C A, Scott A F, et al. OMIM.org:Leveraging knowledge across phenotype-gene relationships[J]. Nucleic Acids Res, 2019, 47(D1):D1038-D1043.
    王与菲, 张海婧, 吴练秋. 基于网络药理学对黄连抗结直肠癌作用机制的分析[J]. 世界科学技术-中医药现代化, 2021, 23(1):136-146.
    郭紫文, 王艳, 陶伟伟, 等. 基于网络药理学、分子对接及细胞实验验证探讨藏红花素改善阿尔茨海默病的作用机制[J]. 中草药, 2025, 56(13):4712-4723.
    王紫柠, 蒲浩, 王清如, 等. 基于网络药理学和实验验证探讨丹皮酚对酒精性肝病小鼠的作用机制[J]. 中草药, 2025, 56(18):6644-6656.
    廖春红, 李凤珍, 刘霞, 等. 基于网络药理学和分子对接技术探讨当归四逆加吴茱萸生姜汤治疗子宫内膜异位症的分子机制[J]. 广西医学, 2024, 46(10):1545-1554.
    曹寒晶, 王煦焱, 高腾, 等. 基于网络药理学和实验验证探讨沙棘治疗代谢相关脂肪性肝病的作用机制[J]. 药物评价研究, 2025, 48(8):2154-2163.
    2026年第57卷第2期
    PDF下载
    25
    7
    引用本文
    BibTeX
    文章信息
    doi: 10.7501/j.issn.0253-2670.2026.02.016
    • 接收时间:2025-10-28
    • 首发时间:2026-09-09
    补充材料
    相关文章
    文章信息
    作者
    出版历史
    • 收稿日期:2025-10-28
    基金
    作者信息
    参考文献
    分享链接
    https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.02.016
    分享至
    全文二维码

    扫描看全文

    引用本文
    BibTeX
    本文的引用情况
    2种不同金属材料的力学参数

    Family
    属数
    Number of
    genus
    种数
    Number of
    species
    占总种数比例
    Percentage of
    total species (%)

    Genus
    种数
    Number of
    species
    占总种数比例
    Percentage of total
    species (%)
    鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
    小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
    多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
    红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
    小菇属 Mycena 11 5.26
    光柄菇属 Pluteus 5 2.39
    红菇属 Russula 17 8.13
    栓菌属 Trametes 5 2.39
    关闭全屏